Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Buspirone Hydrochloride | Redpharm Drug, Inc. while breastfeeding. We will also discuss about common side effects and warnings associated with Buspirone Hydrochloride | Redpharm Drug, Inc..
What is Buspirone Hydrochloride | Redpharm Drug, Inc. used for?
Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The efficacy of buspirone hydrochloride tablets have been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to Generalized Anxiety Disorder (GAD). Many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. The patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. Generalized Anxiety Disorder (300.02) is described in the American Psychiatric Association’s Diagnostic and Statistical Manual, III1 as follows: Generalized, persistent anxiety (of at least 1 month continual duration), manifested by symptoms from three of the four following categories: 1. Motor tension: Shakiness, jitteriness, jumpiness, trembling, tension, muscle aches, fatigability, inability to relax, eyelid twitch, furrowed brow, strained face, fidgeting, restlessness, easy startle. 2. Autonomic hyperactivity: Sweating, heart pounding or racing, cold, clammy hands, dry mouth, dizziness, lightheadedness, paresthesias (tingling in hands or feet), upset stomach, hot or cold spells, frequent urination, diarrhea, discomfort in the pit of the stomach, lump in the throat, flushing, pallor, high resting pulse and respiration rate. 3. Apprehensive expectation: Anxiety, worry, fear, rumination, and anticipation of misfortune to self or others. 4. Vigilance and scanning: Hyperattentiveness resulting in distractibility, difficulty in concentrating, insomnia, feeling "on edge," irritability, impatience. The above symptoms would not be due to another mental disorder, such as a depressive disorder or schizophrenia. However, mild depressive symptoms are common in GAD. The effectiveness of buspirone hydrochloride tablets in long-term use, that is, for more than 3 to 4 weeks, has not been demonstrated in controlled trials. There is no body of evidence available that systematically addresses the appropriate duration of treatment for GAD. However, in a study of long-term use, 264 patients were treated with buspirone hydrochloride tablets for 1 year without ill effect. Therefore, the physician who elects to use buspirone hydrochloride tablets for extended periods should periodically reassess the usefulness of the drug for the individual patient.
I am currently breastfeeding and I want to know if using Buspirone Hydrochloride | Redpharm Drug, Inc. is safe for my kid? Does it have any effect on milk production?
Buspirone hydrochloride is the one and only active ingredient present in Buspirone Hydrochloride | Redpharm Drug, Inc.. Buspirone hydrochloride in itself is a low risk drug for lactation so it is easy to understand that Buspirone Hydrochloride | Redpharm Drug, Inc. also comes in category of Low Risk item while breastfeeding. Below is the summary of Buspirone hydrochloride in breastfeeding.
Buspirone Hydrochloride | Redpharm Drug, Inc. Breastfeeding Analsys
Buspirone hydrochloride while Breastfeeding Low Risk
Avoid a chronic use
Buspirone Hydrochloride | Redpharm Drug, Inc. Breastfeeding Analsys - 2
Buspirone hydrochloride while Breastfeeding
CAS Number: 36505-84-7
Limited information indicates that maternal doses of buspirone up to 45 mg daily produce low levels in milk. Because no information is available on the long-term use of buspirone during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
What should I do if already breastfed my kid after using Buspirone Hydrochloride | Redpharm Drug, Inc.?
During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Buspirone Hydrochloride | Redpharm Drug, Inc. then you shall inform your doctor, But you should not be worried too much as Buspirone Hydrochloride | Redpharm Drug, Inc. comes in category of low risk drug.
My health care provider has asked me to use Buspirone Hydrochloride | Redpharm Drug, Inc., what to do?
Buspirone Hydrochloride | Redpharm Drug, Inc. comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.
If I am using Buspirone Hydrochloride | Redpharm Drug, Inc., will my baby need extra monitoring?
Who can I talk to if I have questions about usage of Buspirone Hydrochloride | Redpharm Drug, Inc. in breastfeeding?
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week